DT Editorial Team

The Developments Today editorial team curating and writing technology, science, and engineering news.

Articles

Defense Secretary Hegseth is meeting with Anthropic CEO Amodei to discuss military AI deployment
The Pentagon is accelerating AI adoption across intelligence, logistics, and autonomous weapons
Anthropic faces a balancing act between its AI safety mission and government revenue opportunities
The meeting could define the framework for how safety-focused AI companies engage with the military

DT Editorial Team·Feb 26, 2026·5 min read·via c4isrnet.com

Ukraine deploys an estimated 3,000-5,000 drones daily as infantry numbers dwindle
Domestic drone production has reached six figures monthly, with a target of one million units in 2026
AI-enabled autonomous navigation is being integrated to counter electronic warfare jamming
Military doctrine is being rewritten to place drones at the center of tactical operations
NATO nations are incorporating lessons from Ukraine's drone transformation into their own planning

DT Editorial Team·Feb 26, 2026·5 min read·via c4isrnet.com

Anthropic acquired Vercept, a startup building AI agents that can operate computers autonomously
The deal came after Meta recruited one of Vercept's co-founders
Computer-use AI agents can interact with any software through its graphical interface
The acquisition strengthens Anthropic's position in the enterprise AI agent market

DT Editorial Team·Feb 26, 2026·4 min read·via techcrunch.com

UK police arrested a software engineer 100 miles from a crime scene based solely on a facial recognition match
The system confused two men of South Asian heritage despite a roughly 10-year age difference
The suspect was held for nearly 10 hours before being released without charges
The case follows a pattern of facial recognition disproportionately misidentifying people of color
Legal proceedings could set precedent for algorithmic misidentification claims in UK courts

DT Editorial Team·Feb 26, 2026·5 min read·via theguardian.com

GSK to acquire 35Pharma for $950M in cash, closing expected Q2 2026
35Pharma's lead pulmonary hypertension candidate is in late-stage clinical trials
Pulmonary hypertension affects 50-70 million people globally with limited treatment options
Deal strengthens GSK's respiratory portfolio alongside its existing asthma and COPD franchises

DT Editorial Team·Feb 25, 2026·5 min read·via endpoints.news

DT Editorial Team·Feb 25, 2026·6 min read·via spectrum.ieee.org

DT Editorial Team·Feb 25, 2026·5 min read·via c4isrnet.com

DT Editorial Team·Feb 25, 2026·5 min read·via endpoints.news

DT Editorial Team·Feb 25, 2026·5 min read·via cleantechnica.com

DT Editorial Team·Feb 25, 2026·5 min read·via therobotreport.com